Locus-specific constitutive and cytokine-induced HLA class I gene expression

Journal of Immunology

Volumn 170, Issue 4, 2003, Pages 1894-1902

  Johnson, David R ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; COMPLEMENTARY DNA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTOKINE; GAMMA INTERFERON; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; MESSENGER RNA; NUCLEIC ACID BINDING PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE LOCUS; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IMMUNITY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0037442001     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.4.1894     Document Type: Article

References (54)

1. Ma, W., P. J. Lehner, P. Cresswell, J. S. Pober, and D. R. Johnson. 1997. Interferon-γ rapidly increases peptide transporter (TAP) subunit expression and peptide transport capacity in endothelial cells. J. Biol. Chem. 272:16585.
2. Johnson, D. R., and B. Mook-Kanamori. 2000. Dependence of elevated HLA class I molecule expression on increased heavy chain, light chain (β2m), TAP, tapasin, and peptide. J. Biol. Chem. 275:16643.
3. Versteeg, R., K. M. Kruse-Wolters, A. C. Plomp, A. van Leeuwen, N. J. Stam, H. L. Ploegh, D. J. Ruiter, and P. I. Schrier. 1989. Suppression of class I human histocompatibility leukocyte antigen by c-Myc is locus specific. J. Exp. Med. 170:621.
4. Johnson, D. R. 2000. Differential expression of human major histocompatibility class I loci: HLA-A, -B, and -C. Hum. Immunol. 61:389.
5. Snyder, S. R., J. Wang, J. F. Waring, and G. D. Ginder. 2001. Identification of CCAAT displacement protein (CDP/cut) as a locus-specific repressor of major histocompatibility complex gene expression in human tumor cells. J. Biol. Chem. 276:5323.
6. Wagtmann, N., S. Rajagopalan, C. Winter, M. Peruzzi, and E. Long. 1995. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3:801.
7. Soong, T., and K. Hui. 1992. Locus-specific transcriptional control of HLA genes. J. Immunol. 149:2008.
8. Liu, K., and K. Kao. 1997. Measurement of relative quantities of different HLA-A and -B mRNAs in cells by reverse transcription-polymerase chain reaction and denaturing gradient gel electrophoresis. J. Immunol. Methods 203:67.
9. Newton, C., A. Graham, L. Heptinstall, S. Powell, C. Summers, N. Kalsheker, J. Smith, and A. Markham. 1989. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 17:2503.
10. Johnson, D. R., B. C. Biedermann, and B. Mook-Kanamori. 2000. Rapid cloning of HLA class I cDNAs by locus specific PCR. J. Immunol. Methods 233:119.
11. Daar, A. S., S. V. Fuggle, J. W. Fabre, A. Ting, and P. J. Morris. 1984. The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 38:287.
12. Goes, N., J. Urmson, M. Hobart, and P. Halloran. 1996. The unique role of interferon-γ in the regulation of MHC expression on arterial endothelium. Transplantation 62:1889.
13. Collinge, M., R. Pardi, and J. R. Bender. 1998. Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion. J. Immunol. 161:1589.
14. Johnson, D., and J. Pober. 1994. HLA class I heavy chain gene promoter elements mediating synergy between tumor necrosis factor and interferons. Mol. Cell. Biol. 14:1322.
15. Min, W., J. Pober, and D. Johnson. 1998. Interferon induction of TAP1: the phosphatase SHP-1 regulates crossover between the IFN-α/β-ISRE pathway and the IFN-γ-GAS pathways. Circ. Res. 83:815.
16. Harada, H., K. Willison, J. Sakakibara, M. Miyamoto, T. Fujita, and T. Taniguchi. 1990. Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell 63:303.
17. Burrone, O. R., R. F. Kefford, D. Gilmore, and C. Milstein. 1985. Stimulation of HLA-A,B,C by IFN-α: the derivation of Molt 4 variants and the differential expression of HLA-A,B,C subsets. EMBO J. 4:2855.
18. Johnson, D., and J. Pober. 1990. Tumor necrosis factor and immune interferon synergistically increase transcription of HLA class I heavy- and light-chain genes in vascular endothelium. Proc. Natl. Acad. Sci. USA 87:5183.
19. Friedman, R., and G. Stark. 1985. α-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences. Nature 314:637.
20. b promoter: enhancer-like sequences and their role in the regulation of class I gene expression. Cell 44:261.
21. Gobin, S., M. van Zutphen, A. Woltman, and P. van den Elsen. 1999. Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. J. Immunol. 163:1428.
22. Gobin, S., V. Keijsers, M. van Zutphen, and P. van den Elsen. 1998. The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor KB. J. Immunol 161:2276.
23. Reid, L. E., A. H. Brasnett, C. S. Gilbert, A. C. Porter, D. R. Gewert, G. R. Stark, and I. M. Kerr. 1989. A single DNA response element can confer inducibility by both α- and γ-interferons. Proc. Natl. Acad. Sci. USA 86:840.
24. 2-microglobulin gene transactivation. J. Immunol. 167:5175.
25. Lechleitner, S., J. Gille, D. Johnson, and P. Petzelbauer. 1998. Interferon enhances tumor necrosis factor-induced vascular cell adhesion molecule 1 (CD106) expression in human endothelial cells by an interferon-related factor 1-dependent pathway. J. Exp. Med. 187:2023.
26. Martin, B., K.-C. Chin, J. Olsen, C. Skinner, A. Dey, K. Ozato, and J. Ting. 1997. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6:591.
27. Gobin, S., A. Peijnenburg, V. Keijsers, and P. van der Elsen. 1997. Site α is crucial for two routes of IFN-γ-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 6:601.
28. Torchia, J., D. W. Rose, J. Inostroza, Y. Kamei, S. Westin, C. K. Glass, and M. G. Rosenfeld. 1997. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387:677.
29. Piskurich, J. F., Y. Wang, M. W. Linhoff, L. C. White, and J. P. Ting. 1998. Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-β-regulated expression of the class II transactivator gene. J. Immunol. 160:233.
30. Xi, H., B. Goodwin, A. T. Shepherd, and G. Blanck. 2001. Impaired class II transactivator expression in mice lacking interferon regulatory factor-2. Oncogene 20:4219.
31. Girdlestone, J., M. Isamat, D. Gewert, and C. Milstein. 1993. Transcriptional regulation of HLA-A and -B: Differential binding of members of the Rel and IRF families of transcription factors. Proc. Natl. Acad. Sci. USA 90:11568.
32. Nagarajan, U. M., P. Louis-Plence, A. DeSandro, R. Nilsen, A. Bushey, and J. M. Boss. 1999. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency [Published erratum appears in Immunity 1999 10:399]. Immunity 10:153.
33. van den Elsen, P. J., A. Peijnenburg, M. C. van Eggermond, and S. J. Gobin. 1998. Shared regulatory elements in the promoters of MHC class I and class II genes. Immunol. Today 19:308.
34. Gobin, S. J., and P. J. van den Elsen. 2001. Locus-specific regulation of HLA-A and HLA-B expression is not determined by nucleotide variation in the X2 box promoter element. Blood 97:1518.
35. Johnson, D. R., I. Douglas, A. Jahnke, S. Ghosh, and J. S. Pober. 1996. A sustained reduction in IκB-β levels may contribute to persistent NF-κB activation in human endothelial cells. J. Biol. Chem. 271:16317.
36. Ledebur, H., and T. Parks. 1995. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokine in human endothelial cells. J. Biol. Chem. 270:933.
37. Shu, H. B., A. B. Agranoff, E. G. Nabel, K. Leung, C. S. Duckett, A. S. Neish, T. Collins, and G. J. Nabel. 1993. Differential regulation of vascular cell adhesion molecule I gene expression by specific NF-κB subunits in endothelial and epithelial cells. Mol. Cell. Biol. 13:6283.
38. Girdlestone, J. 2000. Synergistic induction of HLA class I expression by RelA and CIITA. Blood 95:3804.
39. Lin, R., D. Gewert, and J. Hiscott. 1995. Differential transcriptional activation in vitro by NF-κB/Rel proteins. J. Biol. Chem. 270:3123.
40. Neish, A., M. Read, D. Thanos, R. Pine, T. Maniatis, and T. Collins. 1995. Endothelial interferon regulatory factor I cooperates with NF-κB as a transcriptional activator of vascular cell adhesion molecule 1. Mol. Cell. Biol. 15:2558.
41. Matsuyama, T., T. Kimura, M. Kitagawa, K. Pfeffer, T. Kawakami, N. Watanabe, T. M. Kundig, R. Amakawa, K. Kishihara, A. Wakeham, et al. 1993. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75:83.
42. Waring, J. F., J. E. Radford, L. J. Burns, and G. D. Ginder. 1995. The human leukocyte antigen A2 interferon-stimulated response element consensus sequence binds a nuclear factor required for constitutive expression. J. Biol. Chem. 270:12276.
43. Vallejo, A. N., and L. R. Pease. 1996. The locus-specific enhancer activity of the class I major histocompatibility complex interferon-responsive element is associated with a γ-interferon (IFN)-inducible factor distinct from STAT1α, p48, and IFN regulatory factor-1. J. Biol. Chem. 271:29813.
44. John, J., R. McKendry, S. Pellegrini, D. Flavell, I. M. Kerr, and G. R. Stark. 1991. Isolation and characterization of a new mutant human cell line unresponsive to α and β interferons. Mol. Cell. Biol. 11:4189.
45. Hakem, R., P. Le Bouteillier, A. Jezo-Bremond, K. Harper, D. Campese, and F. Lemonnier. 1991. Differential regulation of HLA-A3 and HLA-B7 MHC class I genes by IFN is due to two nucleotide differences in their IFN response sequences. J. Immunol. 147:2384.
46. Israël, A., A. Kimura, A. Fournier, M. Fellous, and P. Kourilsky. 1986. Interferon response sequence potentiates activity of an enhancer in the promoter region of a mouse H-2 gene. Nature 322:743.
47. 2-microglobulin genes. Immunity 9:531.
48. Quandt, K., K. Frech, H. Karas, E. Wingender, and T. Werner. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:4878.
49. Ono, S. J., and Z. Song. 1995. Mapping of the interaction site of the defective transcription factor in the class II major histocompatibility complex mutant cell line clone-13 to the divergent X2-box. J. Biol. Chem. 270:6396.
50. Peretti, M., J. Villard, E. Barras, M. Zufferey, and W. Reith. 2001. Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP. Mol. Cell. Biol. 21:5699.
51. Montminy, M. R., K. A. Sevarino, J. A. Wagner, G. Mandel, and R. H. Goodman. 1986. Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. Proc. Natl. Acad. Sci. USA 83:6682.
52. Snyder, S. R., J. F. Waring, S. Z. Zhu, S. Kaplan, J. Schultz, and G. D. Ginder. 2001. A 3′-transcribed region of the HLA-A2 gene mediates posttranscriptional stimulation by IFN-γ. J. Immunol. 166:3966.
53. Griffioen, M., I. J. Ouwerkerk, V. Harten, and P. I. Schrier. 2000. HLA-B locusspecific downregulation in human melanoma requires enhancer A as well as a sequence element located downstream of the transcription initiation site. Immunogenetics 52:121.
54. Kushida, M. M., A. Dey, X. L. Zhang, J. Campbell, M. Heeney, J. Carlyle, S. Ganguly, K. Ozato, H. Vasavada, and J. W. Chamberlain. 1997. A 150-base pair 5′ region of the MHC class I HLA-B7 gene is sufficient to direct tissue-specific expression and locus control region activity: the a site determines efficient expression and in vivo occupancy at multiple cis-active sites throughout this region. J. Immunol. 159:4913.